首页> 外文期刊>journal of cardiovascular pharmacology >Intracoronary Linsidomine Abolishes Acetylcholinehyphen;Induced Vasoconstriction of Epicardial Coronary Arteries
【24h】

Intracoronary Linsidomine Abolishes Acetylcholinehyphen;Induced Vasoconstriction of Epicardial Coronary Arteries

机译:冠状动脉内林西多明可消除乙酰胆碱连字符;诱导心外膜冠状动脉血管收缩

获取原文

摘要

SummaryIf the vasodilation of the epicardial coronary arteries caused by linsidomine (SIN-1), the active metabolite of molsidomine, is well established, few data are available concerning the effects of SIN-1 on the acetyl-choline (ACh)-induced vasoconstriction of epicardial coronary arteries. Fourteen patients with mild lesions of the left anterior descending artery (LAD) were studied. Intracoronary blood flow velocity was measured by a Doppler probe placed in the proximal segment of the LAD, and cross-sectional arterial area was assessed by quantitative angiography. After initial hemodynamic parameters were measured, 12 mg papaverine was injected into the left main coronary artery. When hemodynamic parameters returned to baseline values, three increasing concentrations of ACh (5 chi; 10-7, 10-6, and 5 chi; 10-6M) were selectively administered into the LAD in a 3 min period for each concentration. While the infusion of ACh 5 chi; 10-6M was continued, 1 mg SIN-1 was injected as a bolus in the ostium of the left coronary artery. After the injection of papaverine, blood flow increased by 197 $pM 8percnt;, with a trend toward vasoconstriction of the proximal and distal segments of the LAD (p = NS). The ACh injection induced a dose-dependent vasoconstriction, reaching 51 $pM 20percnt; on the distal segment of the LAD at the maximum concentration (p 0.001). After an initial increase in coronary blood flow of 47 $pM 10 and 28 $pM 11percnt; during the first two concentrations of ACh, respectively, the values decreased after the last injection to the level of baseline values. The infusion of SIN-1 antagonized the ACh-induced vasoconstriction, leading to vasodilation of 7.5 $pM 3percnt; (p 0.005) and 16 $pM 7percnt; (p 0.001) of the proximal and distal segments of the LAD, respectively; this was associated with an increase in intracoronary blood flow by 42 $pM 8percnt;. We conclude that intracoronary administration of SIN-1 can antagonize the ACh-induced vasoconstriction of epicardial coronary arteries.
机译:如果由莫西多明的活性代谢产物林西度明(SIN-1)引起的心外膜冠状动脉血管舒张已得到充分证实,但关于SIN-1对乙酰胆碱(ACh)诱导的心外膜冠状动脉血管收缩的影响的数据很少。研究了 14 例左前降支 (LAD) 轻度病变患者。通过放置在LAD近端段的多普勒探头测量冠状动脉内血流速度,并通过定量血管造影评估横截面动脉面积。测量初始血流动力学参数后,将 12 mg 罂粟碱注射到左主冠状动脉中。当血流动力学参数恢复到基线值时,在每种浓度的 3 分钟内选择性地将三种递增浓度的 ACh(5 χ 10-7、10-6 和 5 χ 10-6M)施用到 LAD 中。在继续输注ACh 5χ10-6M的同时,在左冠状动脉口中推注1mg SIN-1。注射罂粟碱后,血流量增加了197$pM 8%,LAD的近端和远端节段有血管收缩的趋势(p = NS)。ACh注射诱导剂量依赖性血管收缩,在最大浓度下LAD远端节段达到51$pM 20&001(p < 0.001)。在前两次ACh浓度期间,冠状动脉血流量分别最初增加47$pM 10和28$pM 11&11&cnt;后,最后一次注射后值降低到基线值的水平。输注SIN-1拮抗ACh诱导的血管收缩,导致LAD近端和远端节段的血管舒张分别为7.5$pM 3%(p < 0.005)和16 $pM 7<& 0.001;这与冠状动脉内血流量增加 42 $pM 8% 有关。我们得出结论,冠状动脉内给药 SIN-1 可以拮抗 ACh 诱导的心外膜冠状动脉血管收缩。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号